Our study shows that new target proteins involved in cancer and inflammatory responses, such as CTNNB1, become a biomarker for exercise anticancer effects in colorectal cancer and contribute to skeletal myopathy in heart failure via direct interaction FoxO [50]. Here, CTNNB1 is linked to colorectal cancer.